Health Condition 1: - Health Condition 2: M363- Arthropathy in other blood disorders Health Condition 3: M873- Other secondary osteonecrosis Health Condition 4: D571- Sickle-cell disease without crisis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.All patients of sickle cell disease 20-60 years with AVN femoral head in FICAT and ARLET Stage 3 and above who will require Primary Total Hip Arthroplasty 2.Patients with valid informed consent and medically fit to undergo surgical procedure
Exclusion criteria
Exclusion criteria: 1. Patients with AVN of aetiology other than Sickle cell disease 2. Age more than 60 years 3. Patient with High-risk behaviour such as chronic alcoholism and IV drug abuse. 4. Patients with Poor cognitive and neurological Function. 5. Patients who have sustained intraoperative Periprosthetic fractures which may hamper the implant stability and precludes immediate weight bearing. 6. Any deformity in the Femur and acetabulum requiring special consideration 7. All Revision Total Hip Arthroplasty
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary aim of the study: To compare the Harris Hip score,Range of Motion,Incidence of loosening of components and Failure which requires further revision total hip arthoplasty .Timepoint: Follow up will be done at 6 week,6 months and 1 year. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess Intraoperative - • Duration of surgical procedure • Blood Loss • Intraoperative complication Postoperative -• Length of Hospital stay • Limb Length Discrepancy • Greater trochanteric pain • Implant Position. • Thromboembolic ComplicationsTimepoint: 3 months and 6 month and 1 year follow-up | — |
Countries
India
Contacts
AIIMS Raipur